J. Ruan et al.
138; therefore, they were retronecine-type PAs and/or PA
N-oxides. Furthermore, the MS2 spectra (Figure 4B) of peaks 1,
2, and 3 all exhibited characteristic ion clusters at m/z 118–120
and 136–138, suggesting that they were all retronecine-type
diester PA N-oxides. The MS2 spectra of peaks 4, 5, and 6 did
not only show the typical N-oxide ion clusters and thus were
retronecine-type PAs. These results further confirmed that the
established characteristic ion clusters of PA N-oxides can be
successfully used to identify rapidly PA N-oxides in PA-containing
natural products even without requiring the reference standards.
Furthermore, with the availability of reference standards, four
ingredients in G. pseudochina were unambiguously identified as
seneciphylline N-oxide (peak 1), senecionine N-oxide (peak 2),
seneciphylline (peak 4), and senecionine (peak 5). According to their
molecular weight and PAs found in Gynura genus,[23] peaks 3 and 6
were identified as seneciphyllinine N-oxide seneciphyllinine. The
structures of seneciphyllinine and its N-oxide are shown in Supple-
mentary Figure 3. Similarly, the herbal extract of G. japonica was also
analyzed by HPLC–MS method, and interestingly the same three PAs
and three PA N-oxides were identified (data not shown).
an official guidance or policy statement of the US Food and Drug
Administration (FDA). No official support or endorsement by the
US FDA is intended or should be inferred.
Supporting Information
Supporting information may be found in the online version of
this article.
REFERENCES
[1] P. P. Fu, H. M. Chiang, Q. Xia, T. Chen, B. H. Chen, J. J. Yin, K. C. Wen, G.
Lin, H. Yu. Quality assurance and safety of herbal dietary supple-
ments. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev.
2009, 27, 91.
[2] P. C. Chan, Q. Xia, P. P. Fu. Ginkgo biloba leave extract: biological,
medicinal, and toxicological effects. J. Environ. Sci. Health C Environ.
Carcinog. Ecotoxicol. Rev. 2007, 25, 211.
[3] P. P. Fu, Q. Xia, G. Lin, M. W. Chou. Pyrrolizidine alkaloids--genotoxicity,
metabolism enzymes, metabolic activation, and mechanisms. Drug
Metab. Rev. 2004, 36, 1.
Previously, using HPLC–MS analysis, several PA N-oxides have
been identified by our research group[21] and others,[22,23] and
the identification of all these PA N-oxides was mainly based on
the corresponding protonated molecular ion ([M + H]+) and/or
protonated molecular dimer adduct ion ([2 M + H]+) and further
confirmed with the comparison of the reference standards. With
the mass spectra reported in these studies, we have retrospec-
tively scrutinized mass spectra of all PA N-oxides identified and
definitively identified the characteristic ion clusters at m/z
118–120 and 136–138 in the mass spectra of retrorsine N-oxide,
senecionine N-oxide, and seneciphylline N-oxide in the study of
Senecionis scandentis,[21] adonifoline N-oxide in the study of
in vitro rat microsomal metabolism of adonifoline,[22] and
seneciphyllinine N-oxide in the study of Gynura segetum.[23]
These findings further support our novel approach to use the
two characteristic mass spectrometric characteristic ion clusters
at m/z 118–120 and 136–138 for the determination of toxic
retronecine-type PA N-oxides in different samples.
[4] N. Li, Q. Xia, J. Ruan, P. P. Fu, G. Lin. Hepatotoxicity and Tumorigenicity
Induced by Metabolic Activation of Pyrrolizidine Alkaloids in Herbs.
Curr. Drug Metab. 2011, 12, 823.
[5] A. R. Mattocks. Toxicity of pyrrolizidine alkaloids. Nature 1968, 217, 723.
[6] G. Lin, Y. Y. Cui, E. M. Hawes. Characterization of rat liver microsomal
metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine
alkaloid. Drug Metab. Dispos. 2000, 28, 1475.
[7] G. Lin, Y. Y. Cui, X. Q. Liu, Z. T. Wang. Species differences in the
in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid
clivorine. Chem. Res. Toxicol. 2002, 15, 1421.
[8] G. Lin, Y. Y. Cui, X. Q. Liu. Gender differences in microsomal meta-
bolic activation of hepatotoxic clivorine in rat. Chem. Res. Toxicol.
2003, 16, 768.
[9] Q. Xia, M. W. Chou, G. Lin, P. P. Fu. Metabolic formation of DHP-derived
DNA adducts from a representative otonecine type pyrrolizidine alka-
loid clivorine and the extract of Ligularia hodgsonnii hook. Chem. Res.
Toxicol. 2004, 17, 702.
[10] G. Lin, J. Y. Wang, N. Li, M. Li, H. Gao, Y. Ji, F. Zhang, H. Wang, Y. Zhou, Y.
Ye, H. X. Xu, J. Zheng. Hepatic sinusoidal obstruction syndrome associ-
ated with consumption of Gynura segetum. J. Hepatol. 2011, 54, 666.
[11] M. T. Williams, B. J. Warnock, J. M. Betz, J. J. Beck, D. R. Gardner, S. T.
Lee, R. J. Molyneux, S. M. Colegate. Detection of High Levels of
Pyrrolizidine-N-oxides in the Endangered Plant Cryptantha crassipes
(Terlingua Creek Cat’s-eye) Using HPLC-ESI-MS. Phytochem. Anal.
2011, 22, 532.
[12] A. R. Mattocks. Chemistry and Toxicology of Pyrrolizidine Alkaloids.
Academic Pr: London, 1986.
[13] J. Yan, Q. Xia, M. W. Chou, P. P. Fu. Metabolic activation of retronecine
and retronecine N-oxide - formation of DHP-derived DNA adducts.
Toxicol. Ind. Health 2008, 24, 181.
[14] M. W. Chou, Y. P. Wang, J. Yan, Y. C. Yang, R. D. Beger, L. D. Williams,
D. R. Doerge, P. P. Fu. Riddelliine N-oxide is a phytochemical and
mammalian metabolite with genotoxic activity that is comparable
to the parent pyrrolizidine alkaloid riddelliine. Toxicol. Lett. 2003,
145, 239
[15] Y. P. Wang, J. Yan, P. P. Fu, M. W. Chou. Human liver microsomal reduc-
tion of pyrrolizidine alkaloid N-oxides to form the corresponding
carcinogenic parent alkaloid. Toxicol. Lett. 2005, 155, 411.
[16] R. J. Molyneux, A. E. Johnson, J. D. Olsen, D. C. Baker. Toxicity of
pyrrolizidine alkaloids from Riddell groundsel (Senecio riddellii) to
cattle. Am. J. Vet. Res. 1991, 52, 146.
[17] H. G. Mol, R. C. Van Dam, P. Zomer, P. P. Mulder. Screening of plant
toxins in food, feed and botanicals using full-scan high-resolution
(Orbitrap) mass spectrometry. Food Addit. Contam. Part A Chem.
Anal. Control Expo. Risk Assess. 2011, 28, 1405.
[18] X. Yang, L. Yang, A. Xiong, D. Li, Z. Wang. Authentication of Senecio
scandens and S. vulgaris based on the comprehensive secondary
metabolic patterns gained by UPLC-DAD/ESI-MS. J. Pharm. Biomed.
Anal. 2011, 56, 165.
CONCLUSIONS
Our study has, for the first time, found that the characteristic ion
clusters were unique determinants to distinguish between PA
N-oxides and PAs and also identify different subtypes among
retronecine-type PA N-oxides. Our findings provide a novel and
specific analytical method to differentiate PA N-oxides from PAs
in PA-containing natural products. The discrimination of PA
N-oxides from PAs will allow predict the risk of PA intoxication
and make suitable quality control of PA-containing products
and thus reducing the potential high risk of PA poisonings.
Acknowledgement
The authors greatly acknowledge the funding support from
Research Grant Council of Hong Kong Special Administrative Re-
gion, China (GRF Grant Project no. CUHK2140690) to the present
study. The financial support from the National Natural Science
Funds for Distinguished Young Scholar (No. 30925043) is also
greatly acknowledged. They thank Dr Po-Chuen Chan of NTP
for supplying riddelliine, Dr John A. Edgar of CSIRO for supplying
lasiocarpine, and Prof. Hai Shen Chen of Secondary Military
Medical University for supplying Platyphylline. This article is not
[19] C. Wang, Y. Li, J. Gao, Y. He, A. Xiong, L. Yang, X. Cheng, Y. Ma, Z.
Wang. The comparative pharmacokinetics of two pyrrolizidine
wileyonlinelibrary.com/journal/jms
Copyright © 2012 John Wiley & Sons, Ltd.
J. Mass. Spectrom. 2012, 47, 331–337